Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890735944> ?p ?o ?g. }
- W2890735944 endingPage "716.e3" @default.
- W2890735944 startingPage "710" @default.
- W2890735944 abstract "Identification of a safe and effective medical therapy for abdominal aortic aneurysm (AAA) disease remains a significant unmet medical need. Recent small cohort studies indicate that metformin, the world's most commonly prescribed oral hypoglycemic agent, may limit AAA enlargement. We sought to validate these preliminary observations in a larger cohort.All patients with asymptomatic AAA disease managed in the Veterans Affairs Health Care System between 2003 and 2013 were identified by International Classification of Diseases, Ninth Revision codes. Those with a concomitant diagnosis of diabetes mellitus who also received two or more abdominal imaging studies (computed tomography, magnetic resonance imaging, or ultrasound) documenting the presence and size of an AAA, separated by at least 1 year, were included for review. Maximal AAA diameters were determined from radiologic reports. Further data acquisition was censored after surgical AAA repair, when performed. Comorbidities, active smoking status, and outpatient medication records (within 6 months of AAA diagnosis) were also queried. Yearly AAA enlargement rates, as a function of metformin treatment status, were compared using two statistical models expressed in millimeters per year: a multivariate linear regression (model 1) and a multivariate mixed-effects model with random intercept and random slope (model 2).A total of 13,834 patients with 58,833 radiographic records were included in the analysis, with radiology imaging follow-up of 4.2 ± 2.6 years (mean ± standard deviation). The average age of the patients at AAA diagnosis was 69.8 ± 7.8 years, and 39.7% had a metformin prescription within ±6 months of AAA. The mean growth rate for AAAs in the entire cohort was 1.4 ± 2.0 mm/y by model 1 analysis and 1.3 ± 1.6 mm/y by model 2 analysis. The unadjusted mean rate of AAA growth was 1.2 ± 1.9 mm/y for patients prescribed metformin compared with 1.5 ± 2.2 mm/y for those without (P < .001), a 20% decrease. This effect remained significant when adjusted for variables relevant on AAA progression: metformin prescription was associated with a reduction in yearly AAA growth rate of -0.23 mm (95% confidence interval, -0.35 to -0.16; P < .001) by model 1 analysis and 0.20 mm/y (95% confidence interval, -0.26 to -0.14; P < .001) by model 2 analysis. A subset analysis of 7462 patients with baseline AAA size of 35 to 49 mm showed a similar inhibitory effect (1.4 ± 2.0 mm/y to 1.7 ± 2.2 mm/y; P < .001). Patients' factors associated with an increased yearly AAA growth rate were baseline AAA size, metastatic solid tumors, active smoking, chronic obstructive pulmonary disease, and chronic renal disease. Factors associated with decreased yearly AAA growth rates included prescriptions for angiotensin II type 1 receptor blockers or sulfonylureas and the presence of diabetes-related complications.In a nationwide analysis of diabetic Veterans Affairs patients, prescription for metformin was associated with decreased AAA enlargement. These findings provide further support for the conduct of prospective clinical trials to test the ability of metformin to limit progression of early AAA disease." @default.
- W2890735944 created "2018-09-27" @default.
- W2890735944 creator A5000229807 @default.
- W2890735944 creator A5008866393 @default.
- W2890735944 creator A5021278728 @default.
- W2890735944 creator A5028630773 @default.
- W2890735944 creator A5035296447 @default.
- W2890735944 creator A5066732440 @default.
- W2890735944 creator A5081914300 @default.
- W2890735944 creator A5091648407 @default.
- W2890735944 date "2019-03-01" @default.
- W2890735944 modified "2023-10-11" @default.
- W2890735944 title "Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population" @default.
- W2890735944 cites W1597382019 @default.
- W2890735944 cites W1719957533 @default.
- W2890735944 cites W1825487542 @default.
- W2890735944 cites W1963738625 @default.
- W2890735944 cites W1992012146 @default.
- W2890735944 cites W2004598694 @default.
- W2890735944 cites W2009712337 @default.
- W2890735944 cites W2013531450 @default.
- W2890735944 cites W2033000407 @default.
- W2890735944 cites W2046782528 @default.
- W2890735944 cites W2052402508 @default.
- W2890735944 cites W2056435044 @default.
- W2890735944 cites W2101729820 @default.
- W2890735944 cites W2103963368 @default.
- W2890735944 cites W2129168200 @default.
- W2890735944 cites W2130622683 @default.
- W2890735944 cites W2135742242 @default.
- W2890735944 cites W2141224774 @default.
- W2890735944 cites W2144306226 @default.
- W2890735944 cites W2149932046 @default.
- W2890735944 cites W2338299575 @default.
- W2890735944 cites W2473725818 @default.
- W2890735944 cites W2511762120 @default.
- W2890735944 cites W2519342050 @default.
- W2890735944 cites W2605719386 @default.
- W2890735944 cites W2611663672 @default.
- W2890735944 cites W2680386216 @default.
- W2890735944 cites W2776247479 @default.
- W2890735944 doi "https://doi.org/10.1016/j.jvs.2018.06.194" @default.
- W2890735944 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6706071" @default.
- W2890735944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30197158" @default.
- W2890735944 hasPublicationYear "2019" @default.
- W2890735944 type Work @default.
- W2890735944 sameAs 2890735944 @default.
- W2890735944 citedByCount "80" @default.
- W2890735944 countsByYear W28907359442018 @default.
- W2890735944 countsByYear W28907359442019 @default.
- W2890735944 countsByYear W28907359442020 @default.
- W2890735944 countsByYear W28907359442021 @default.
- W2890735944 countsByYear W28907359442022 @default.
- W2890735944 countsByYear W28907359442023 @default.
- W2890735944 crossrefType "journal-article" @default.
- W2890735944 hasAuthorship W2890735944A5000229807 @default.
- W2890735944 hasAuthorship W2890735944A5008866393 @default.
- W2890735944 hasAuthorship W2890735944A5021278728 @default.
- W2890735944 hasAuthorship W2890735944A5028630773 @default.
- W2890735944 hasAuthorship W2890735944A5035296447 @default.
- W2890735944 hasAuthorship W2890735944A5066732440 @default.
- W2890735944 hasAuthorship W2890735944A5081914300 @default.
- W2890735944 hasAuthorship W2890735944A5091648407 @default.
- W2890735944 hasBestOaLocation W28907359441 @default.
- W2890735944 hasConcept C126322002 @default.
- W2890735944 hasConcept C126838900 @default.
- W2890735944 hasConcept C134018914 @default.
- W2890735944 hasConcept C141071460 @default.
- W2890735944 hasConcept C143409427 @default.
- W2890735944 hasConcept C195910791 @default.
- W2890735944 hasConcept C2776098176 @default.
- W2890735944 hasConcept C2777910003 @default.
- W2890735944 hasConcept C2779306644 @default.
- W2890735944 hasConcept C2779993416 @default.
- W2890735944 hasConcept C2780323712 @default.
- W2890735944 hasConcept C2908647359 @default.
- W2890735944 hasConcept C555293320 @default.
- W2890735944 hasConcept C71924100 @default.
- W2890735944 hasConcept C72563966 @default.
- W2890735944 hasConcept C99454951 @default.
- W2890735944 hasConceptScore W2890735944C126322002 @default.
- W2890735944 hasConceptScore W2890735944C126838900 @default.
- W2890735944 hasConceptScore W2890735944C134018914 @default.
- W2890735944 hasConceptScore W2890735944C141071460 @default.
- W2890735944 hasConceptScore W2890735944C143409427 @default.
- W2890735944 hasConceptScore W2890735944C195910791 @default.
- W2890735944 hasConceptScore W2890735944C2776098176 @default.
- W2890735944 hasConceptScore W2890735944C2777910003 @default.
- W2890735944 hasConceptScore W2890735944C2779306644 @default.
- W2890735944 hasConceptScore W2890735944C2779993416 @default.
- W2890735944 hasConceptScore W2890735944C2780323712 @default.
- W2890735944 hasConceptScore W2890735944C2908647359 @default.
- W2890735944 hasConceptScore W2890735944C555293320 @default.
- W2890735944 hasConceptScore W2890735944C71924100 @default.
- W2890735944 hasConceptScore W2890735944C72563966 @default.
- W2890735944 hasConceptScore W2890735944C99454951 @default.
- W2890735944 hasIssue "3" @default.
- W2890735944 hasLocation W28907359441 @default.